Work

Abstract 3090: VRK1 inhibition leverages paralog synthetic lethality to selectively target VRK2-deficient cancer cells

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-3090

Authors: Kiera M. Vassallo, Kevin M. Cottrell, Katarzyna B. Handing, Mu-Sen Liu, Alvin Lu, Alice Tsai, Maria Dam Ferdinez, Patrick McCarren, Sirimas Sudsakorn, Jannik N. Andersen, Kimberly J. Briggs

Institution: Tango Therapeutics (United States)

Language: English

Topic: Cancer Mechanisms and Therapy

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148815131

Cites:

Cited by:

Related to: